Profile
ZJYL ISRG BDX ALC RMD WST
Company Name Jin Medical International Ltd. Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc. West Pharmaceutical Services, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $485.30M $156.82B $68.58B $46.06B $28.95B $20.74B
Employees 0.25K 13.68K 70.00K 25.00K 10.14K 10.60K
CEO Mr. Erqi Wang Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM Mr. Eric M. Green
Ratings
ZJYL ISRG BDX ALC RMD WST
Quant Rating Score 3 3 3 3 3 3
Quant Rating Neutral Neutral Neutral Neutral Neutral Neutral
Trading
ZJYL ISRG BDX ALC RMD WST
Last Close $3.18 $441.3 $237.3 $93.37 $197.04 $284.76
High 52 $276.11 $461.12 $283.59 $93.36 $225.35 $413
Low 52 $2.49 $258.49 $221.47 $69.56 $134.65 $277.16
Price vs. 52 Week High -98.85 % -4.3 % -16.32 % 0.01 % -12.56 % -31.05 %
Price vs. 52 Week Low 27.71 % 70.72 % 7.15 % 34.23 % 46.33 % 2.74 %
Total Return
ZJYL ISRG BDX ALC RMD WST
1 Month Return 23.74 % -0.86 % 2.75 % 4.08 % 2.85 % -13.38 %
3 Month Return -21.29 % 17.58 % 2.48 % 18.53 % -9.64 % -20.99 %
6 Month Return -98.21 % 17.76 % 0.27 % 22.86 % 3.62 % -21.2 %
9 Month Return -67.05 % 70.4 % -5.68 % 33.37 % 46.33 % -11.27 %
YTD Return -98.72 % 30.81 % -2.68 % 19.52 % 14.54 % -19.13 %
1 Year Return -70.47 % 36.39 % -16.32 % 10.11 % -11.04 % -19.76 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ZJYL ISRG BDX ALC RMD WST
Dividend Yield Percentage (TTM) - - 1.58 % 0.28 % 0.97 % 0.21 %
Dividend Paid and Capex Coverage Ration (TTM) 19.88 % 1.16 % 2.05 % 1.66 % 2.97 % 1.66 %
Dividend Per Share (TTM) - - 3.76 % 0.26 % 1.92 % 0.6 %
Payout Ratio (TTM) - - 82.6 % 11.25 % 28.85 % 11.07 %
Growth
ZJYL ISRG BDX ALC RMD WST
Asset Growth 57.14 % 19.02 % -0.29 % 1.35 % 32.49 % 5.88 %
Gross Profit Growth 9.46 % 12.71 % -3.62 % 18.11 % 16.37 % -0.62 %
Revenue Growth 3.29 % 14.49 % 2.66 % 15.77 % 18.02 % 2.18 %
Revenue 3 Year -93.25 % 63.36 % 10.28 % 46.5 % 40.45 % 36.66 %
Revenue 5 Year -94.64 % 85.79 % 9.38 % 39.86 % 75.54 % 70.83 %
Revenue 10 Year -94.64 % 223.26 % 63.97 % 53.48 % 171.6 % 101.93 %
EBIT Growth 34.58 % 45.86 % -7.49 % 87.58 % 13.15 % -7.9 %
Net Income Growth 6.34 % 35.98 % -16.58 % 190.75 % 15.15 % 1.28 %
Net Income 3 Yeari Growth Per Share -92.81 % 69.43 % 65.46 % 281.94 % 41.99 % 70.48 %
Net Income 5 Yeari Growth Per Share -95.65 % 54.83 % 330.62 % 525.33 % 176.65 % 185.26 %
Net Income 10 Yeari Growth Per Share -95.65 % 175.41 % -21.76 % 225.89 % 184.65 % 394.98 %
Operating Income Growth 34.58 % 45.86 % -7.49 % 87.58 % 13.15 % -7.9 %
Operating Cash Flow Growth (CFG) 96.53 % 21.67 % 13.52 % 21.73 % 97.44 % 7.25 %
Operating 3 Year CFG -93.16 % 22.09 % -17.7 % 78.55 % -15.01 % 63.45 %
Operating 5 Year CFG 112.92 % 50.62 % -5.85 % 28.82 % 33.54 % 167.61 %
Operating 10 Year CFG 112.92 % 111.85 % 35.21 % 11.44 % 67.64 % 229.88 %
EPS Growth -94.18 % 37.63 % -16.19 % 201.43 % 14.61 % 1.4 %
EPS Diluted Growth -94.18 % 37.81 % -15.99 % 198.57 % 14.91 % 1.94 %
Book Value Per Share -91.32 % 21.29 % 1.5 % 4.44 % 22.3 % 7.45 %
Share Holder 3 Year Equity Growth Per Share -87.76 % 36.28 % 5.73 % 8.65 % 62.66 % 54.52 %
Share Holder 5 Year Equity Growth Per Share -87.65 % 93.27 % 10.89 % -9.73 % 95.11 % 105.22 %
Share Holder 10 Year Equity Growth Per Share -87.65 % 290.63 % 248.77 % -13.54 % 149.77 % 197.74 %
Dividend Per Share Growth - - 2.5 % 15.62 % 4.77 % 5.5 %
Dividend 3 Year Growth Per Share - - 5.8 % - 12.84 % 17.87 %
Dividend 5 Year Growth Per Share - - 8.45 % - 25.93 % 34.66 %
Dividend 10 Year Growth Per Share - - 96.74 % - 158.81 % 99.23 %
Debt Growth - -4.26 % -1.16 % 1.48 % 72.19 % -2.8 %
Free Cash Flow Growth 94.25 % -21.79 % 27.41 % 21.44 % 186.66 % -5.67 %
Updated On 30 Sep 2023 31 Dec 2023 30 Sep 2023 31 Dec 2023 30 Jun 2023 31 Dec 2023
Profitability
ZJYL ISRG BDX ALC RMD WST
Gross Profit Margin TTM 34.35 % 66.86 % 41.25 % 55.6 % 57.28 % 35.73 %
Return on Assets TTM 10.44 % 12.57 % 2.46 % 3.54 % 14.06 % 15.04 %
Return on Equity TTM 14.41 % 15.36 % 5.19 % 5.14 % 21.92 % 19.08 %
Return on Capital Employed TTM 14.24 % 12.88 % 4.64 % 5.08 % 20.09 % 20.72 %
Net Income Per EBT TTM 89.25 % 93.85 % 81.08 % 108.82 % 80.95 % 85.87 %
EBT Per Ebit TTM 112.67 % 114.25 % 75.69 % 69.52 % 97.52 % 103.3 %
EBIT Per Revenue TTM 13.88 % 25.79 % 11.02 % 14.3 % 27.31 % 20.57 %
Cash Flow To Debt Ratio TTM 79.94 % 1671.71 % 20.88 % 32.36 % 116.24 % 331.45 %
Receivables Turnover TTM 2.89 6.09 7.7 5.28 5.44 5.73
Payables Turnover TTM 4.76 12.91 2.38 5.26 10.7 8.73
Inventory Turnover TTM 3.2 1.81 3.59 1.85 2.29 4.41
Fixed Asset Turnover TTM 1661.65 % 183.94 % 299.14 % 206.93 % 647.17 % 175.95 %
Asset Turnover TTM 74.78 % 45.48 % 36.41 % 32.77 % 65.23 % 82.44 %
Operating Cash Flow Per Share TTM 0.02 4.05 12.99 3.33 8.16 10.31
Free Cash Flow Per Share TTM 0.02 0.54 10.45 1.57 7.29 4.89
Cash Per Share TTM 10.71 % 1340.06 % 1112.54 % 232.28 % 176.54 % 611.23 %
Operating Cash Flow Sales Ratio TTM 13.36 % 18.96 % 19.08 % 16.99 % 26.97 % 26.15 %
Free Cash Flow Operating Cash Flow Ratio TTM 94.97 % 13.43 % 80.46 % 47.02 % 89.38 % 47.46 %
Cash Flow Coverage Ratios TTM 79.94 % 1671.71 % 20.88 % 32.36 % 116.24 % 331.45 %
Price To Free Cash Flows Ratio TTM 155.42 812.95 22.66 59.52 27.02 58.09
Price To Operating Cash Flows Ratio TTM 147.04 109.1 18.27 28.01 24.16 27.63
Price Cash Flow Ratio TTM 147.04 109.1 18.27 28.01 24.16 27.63
Income Statement (TTM)
ZJYL ISRG BDX ALC RMD WST
Revenue $0.02B $7.12B $19.37B $10.09B $4.22B $2.95B
Gross Profit $0.01B $4.73B $8.17B $5.61B $2.36B $1.13B
Gross Profit Ratio 34.23% 66.39% 42.17% 55.57% 55.78% 38.28%
EBITDA $0B $2.19B $4.72B $2.56B $1.34B $0.88B
Net Income $0B $1.8B $1.48B $0.97B $0.9B $0.59B
EPS Diluted 0.02 5.03 4.94 2.09 6.09 7.88
Balance Sheet (MRQ)
ZJYL ISRG BDX ALC RMD WST
Long Term Debt $0B $-0.08B $14.74B $4.59B $1.55B $0.16B
Total Liabilities $0.01B $2.04B $26.98B $8.99B $2.62B $0.95B
Total Equity $0.02B $13.4B $25.8B $20.62B $4.13B $2.88B
Total Investments $0.01B $4.59B $0.01B $0.28B $-0.13B $0.21B
Total Debt $0B $0.09B $15.88B $5.14B $1.58B $0.31B
Total Assets $0.03B $15.44B $52.78B $29.6B $6.75B $3.83B
Cash Flow Statement (TTM)
ZJYL ISRG BDX ALC RMD WST
Net Income $0B $1.82B $1.53B $1.04B $0.9B $0.59B
Inventory $0B $-0.71B $-0.02B $-0.29B $-0.25B $-0.01B
Dividends Paid $0B $0B $-1.11B $-0.12B $-0.26B $-0.06B
Operating Cash Flow $0B $1.81B $2.99B $1.48B $0.69B $0.78B
Capital Expenditure $-0B $-1.06B $-0.87B $-0.91B $-0.13B $-0.36B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 2.46
ALC Alcon Inc. 93.37
ANGO AngioDynamics, Inc. 7.65
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 146.66
ATRC AtriCure, Inc. 22.1
ATRI Atrion Corporation 457.65
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 1.42
AZTA Azenta, Inc. 60.22
BAX Baxter International Inc. 35.51
BDX Becton, Dickinson and Company 237.3
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.81
BLFS BioLife Solutions, Inc. 24.04
COO The Cooper Companies, Inc. 93.21
DXR Daxor Corporation 9
EKSO Ekso Bionics Holdings, Inc. 1.3
FEMY Femasys Inc. 1.14
GCTK GlucoTrack, Inc. 1.36
ETFs With Exposure to ZJYL
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0 43.72
VT Vanguard Total World Stock Index Fund 0 113.54
VSS Vanguard FTSE All-World ex-US Small Capital Index Fund 0 119.87
PGJ Invesco Golden Dragon China ETF 0.337 22.1
VFSAX Vanguard FTSE All-World ex-US Small-Cap Index Fund Admiral Shares 0 29.51
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0 36.52
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0 40.21
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0 92.37
VTWIX Vanguard Total World Stock Index I 0 231.77
Unlock